Congenital heart disease is the most common and leading cause of birth-defect related deaths [1]. While many of these patients have damaged or deformed hearts that require transplantation, recovery may be possible for a select population [2]. Extracorporeal membrane oxygenation or ventricular assist devices are often used in a bridge-to-recovery situation to sustain a patient with the expectation of recovery of natural ventricular function [3].

This content is only available via PDF.
You do not currently have access to this content.